• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Scandinavian Real Heart

19.90 SEK+0.76 %10/7 17:29
Less than 1K followers

HEART

First North Stockholm

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
+0.76 %
-15.32 %
+45.26 %
+38.19 %
+43.67 %
+51.29 %
-70.63 %
-93.00 %
-87.11 %

Scandinavian Real Heart operates in the medical technology sector. The company conducts research and development in observations of the physiology of the heart. The development of the company's product, a complete artificial heart, is taking place in collaboration with cardiac surgeons, researchers and engineers. The focus is on developing patented solutions that can imitate the blood circulation of the natural human heart, with the goal of being used by patients diagnosed with heart failure. The company was founded in 2007.

Read more
Market cap
169.11M SEK
Turnover
14.07K SEK
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
EPS and dividend
Financial calendar
28/8
2026

Interim report Q2'26

All
Press releases
3rd party
ShowingAll content types

Revenue and EBIT-%

Revenue K

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Press release2026-06-16 08:30

Realheart Releases Recording of the 2026 Annual General Meeting

Scandinavian Real Heart
Regulatory press release2026-05-28 21:35

Bulletin from the Annual General Meeting of Scandinavian Real Heart AB on May 28, 2026

Scandinavian Real Heart
Regulatory press release2026-05-28 21:35

Kommuniké från årsstämman i Scandinavian Real Heart AB den 28 maj 2026

Scandinavian Real Heart

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Press release2026-05-28 08:40

Realheart’s CEO to Present the Company’s Continued Development for Realheart® TAH at the Annual General Meeting on May 28

Scandinavian Real Heart
Press release2026-05-28 08:30

Realheart Granted Patent Approval in Australia

Scandinavian Real Heart
Press release2026-05-28 08:20

Realheart Granted Patent Approval in China

Scandinavian Real Heart
Regulatory press release2026-04-24 08:00

NOTICE TO ATTEND THE ANNUAL GENERAL MEETING IN SCANDINAVIAN REAL HEART AB

Scandinavian Real Heart
Regulatory press release2026-04-24 08:00

KALLELSE TILL ÅRSSTÄMMA I SCANDINAVIAN REAL HEART AB

Scandinavian Real Heart
Press release2026-04-21 11:15

Peer-Reviewed Article Shows Superior Hemolysis Profile in Realheart® TAH Compared to Market-Leading Device

Scandinavian Real Heart
Press release2026-04-09 08:30

Realheart® TAH and Key Collaborators Featured in New SVT Documentary Series

Scandinavian Real Heart
Regulatory press release2026-03-20 08:30

Realheart Releases Annual Report for 2025

Scandinavian Real Heart
Regulatory press release2026-03-20 08:30

Realheart publicerar årsredovisning för 2025

Scandinavian Real Heart
Press release2026-03-04 08:30

Realheart Receives Patent Approval in India

Scandinavian Real Heart
Regulatory press release2026-02-19 08:30

Year-End Report H2 2025

Scandinavian Real Heart
Press release2026-02-11 08:30

Realheart Receives Patent Approval in Europe

Scandinavian Real Heart
Regulatory press release2026-01-28 17:23

Scandinavian Real Heart AB announces outcome of the Company's rights issue

Scandinavian Real Heart
Regulatory press release2026-01-28 17:23

Scandinavian Real Heart AB offentliggör utfall i Bolagets företrädesemission

Scandinavian Real Heart
Press release2026-01-14 08:30

Relheart’s CEO Presents the Company and Current Share Issue – Recording Now Available

Scandinavian Real Heart
Press release2026-01-14 08:30

Relhearts vd presenterar bolaget och aktuell emission – inspelning nu tillgänglig

Scandinavian Real Heart
Press release2026-01-13 09:31

The subscription period in Realheart's rights issue starts today, January 13, 2026.

Scandinavian Real Heart